Target intelligence / Profile preview

Liver sinusoidal endothelial cell (LSEC) and local vasculature (LSEC)

Target
LSEC
Molecular classification
Other
01

Overview

Liver sinusoidal endothelial cells (LSECs) are highly specialized, fenestrated cells that line the hepatic sinusoids, acting as a selective barrier between the blood and hepatocytes. They are characterized by the absence of a basement membrane and the presence of numerous pores (fenestrae), which facilitate the rapid exchange of nutrients and waste products (Sørensen et al., 2015, Journal of Hepatology). LSECs serve as a major scavenger system in the body, utilizing receptors like Stabilin-2 to clear circulating macromolecules and pathogens (Geraud et al., 2012, American Journal of Physiology). In chronic liver disease, LSECs undergo capillarization—a process involving the loss of fenestrae and the formation of a basement membrane—which contributes to portal hypertension and the progression of fibrosis (Iwakiri & Trebicka, 2021, Nature Reviews Gastroenterology & Hepatology). While LSECs are a cellular population rather than a single molecular target, they are critical sites for therapeutic intervention using drugs like statins or VEGF inhibitors to restore vascular function or deliver targeted therapies to the liver (Marrone et al., 2013, Journal of Hepatology).

Other names
LSECsHepatic sinusoidal endothelial cellsLiver sinusoidsSinusoidal endotheliumHepatic microvasculature
02

Mechanism of action

Modulation of nitric oxide (NO) signaling, inhibition of vascular endothelial growth factor (VEGF) pathways, and activation of scavenger receptors for clearance of macromolecules.

03

Biological functions

Immune responseBlood filtrationVascular tone regulationEndocytosisAntigen presentationOther
04

Disease associations

CancerInflammationLiver fibrosisCirrhosisPortal hypertensionOther
05

Safety considerations

Impaired hepatic clearanceSystemic hypertensionExacerbation of liver fibrosisInterference with hepatic immune tolerance
06

Interacting drugs

Bevacizumab

4 more in the full profile.

07

Biomarkers

CD31 (PECAM-1)CD32b (FcγRIIb)Stabilin-2LYVE-1Hyaluronic acid

Beyond the preview

Go deeper on Liver sinusoidal endothelial cell (LSEC) and local vasculature (LSEC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liver sinusoidal endothelial cell (LSEC) and local vasculature (LSEC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call